Moderna announced that it has developed a working cancer vaccine, and the company's shares soared. Portfolio manager Heikki Urpelainen explains whether there is still time to join the price rise and which company could make the next medical breakthrough.
Moderna announced that it has developed a working cancer vaccine, and the company's shares soared. Portfolio manager Heikki Urpelainen explains whether there is still time to join the price rise and which company could make the next medical breakthrough.